KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Cash from Operations (2016 - 2026)

Pfizer has reported Cash from Operations over the past 18 years, most recently at 2615000000.0 for Q1 2026.

  • Quarterly Cash from Operations rose 11.99% to 2615000000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 11984000000.0 through Mar 2026, up 56.31% year-over-year, with the annual reading at 11704000000.0 for FY2025, 8.16% down from the prior year.
  • Cash from Operations was 2615000000.0 for Q1 2026 at Pfizer, down from 5348000000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 20685000000.0 in Q4 2022 and troughed at 1781000000.0 in Q2 2024.
  • The 5-year median for Cash from Operations is 3456000000.0 (2023), against an average of 4249800000.0.
  • Year-over-year, Cash from Operations tumbled 114.79% in 2023 and then surged 114.22% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 20685000000.0 in 2022, then plummeted by 74.67% to 5240000000.0 in 2023, then rose by 14.94% to 6023000000.0 in 2024, then decreased by 11.21% to 5348000000.0 in 2025, then plummeted by 51.1% to 2615000000.0 in 2026.
  • Per Business Quant, the three most recent readings for PFE's Cash from Operations are 2615000000.0 (Q1 2026), 5348000000.0 (Q4 2025), and 4603000000.0 (Q3 2025).